- Report
- September 2024
- 330 Pages
Global
From €4512EUR$5,000USD£3,910GBP
- Report
- April 2024
- 279 Pages
Global
From €4512EUR$5,000USD£3,910GBP
- Report
- August 2024
- 163 Pages
Global
From €2698EUR$2,990USD£2,338GBP
- Report
- April 2024
- 447 Pages
Global
From €3790EUR$4,200USD£3,284GBP
- Report
- August 2023
- 202 Pages
South Africa
From €3158EUR$3,500USD£2,737GBP
- Report
- November 2022
- 230 Pages
Global
From €3384EUR$3,750USD£2,932GBP
- Report
- October 2022
- 270 Pages
Global
From €3384EUR$3,750USD£2,932GBP
- Report
- September 2022
- 232 Pages
Global
From €3158EUR$3,500USD£2,737GBP
- Report
- July 2022
- 317 Pages
Global
From €3158EUR$3,500USD£2,737GBP
- Report
- June 2025
- 571 Pages
Global
From €4052EUR$4,490USD£3,511GBP
- Report
- December 2024
- 175 Pages
Global
From €4512EUR$5,000USD£3,910GBP
- Report
- August 2024
- 133 Pages
North America
From €3610EUR$4,000USD£3,128GBP
- Report
- July 2024
- 80 Pages
Japan
From €3158EUR$3,500USD£2,737GBP
- Report
- November 2023
- 190 Pages
Global
From €4061EUR$4,500USD£3,519GBP
- Report
- March 2025
- 183 Pages
Global
From €4061EUR$4,500USD£3,519GBP
- Report
- July 2024
Global
From €4467EUR$4,950USD£3,871GBP
- Report
- June 2024
Global
From €4467EUR$4,950USD£3,871GBP
- Report
- June 2023
- 69 Pages
Global
From €4467EUR$4,950USD£3,871GBP
- Drug Pipelines
- April 2025
- 180 Pages
Global
From €2256EUR$2,500USD£1,955GBP
- Clinical Trials
- April 2025
- 60 Pages
Global
From €1354EUR$1,500USD£1,173GBP

The Antibodies market is a subset of the Immune Disorders Drugs market, which focuses on treatments for conditions related to the immune system. Antibodies are proteins produced by the body to fight off foreign substances, such as bacteria and viruses. They are used to treat a variety of immune-related conditions, including autoimmune diseases, allergies, and cancer. Antibodies can be used in combination with other drugs, such as steroids, to reduce inflammation and improve symptoms. They can also be used to target specific cells or proteins in the body, allowing for more targeted treatments.
The Antibodies market is highly competitive, with a number of companies offering a variety of products. Companies such as AbbVie, Amgen, and Biogen are leading the way in developing and marketing antibodies for the treatment of immune-related conditions. Other companies, such as Genentech and Regeneron, are also active in the market, offering a range of products for different conditions. Show Less Read more